Gary Siegel
Comptroller/Controller/Auditor presso ACTINIUM PHARMACEUTICALS, INC.
Provenienza dei contatti di primo grado di Gary Siegel
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 38 | |
Genta, Inc.
 Genta, Inc. Pharmaceuticals: MajorHealth Technology Genta, Inc. is in the process of bankruptcy. The company formerly engages in pharmaceutical research and development. Genta was founded on February 4, 1988 and is headquartered in Berkeley Heights, NJ.
20
| Extinct | Pharmaceuticals: Major | 20 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Gary Siegel tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| IMMUNOMEDICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| GERON CORPORATION | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| PROGENICS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Doctorate Degree Doctorate Degree | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Drexel University | College/University | Graduate Degree Corporate Officer/Principal | |
| Birla Institute of Technology & Science | College/University | Undergraduate Degree | |
| MITHRA PHARMACEUTICALS S.A. | Pharmaceuticals: Major | Chairman | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| The University of Texas at Austin | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Louisiana Tech University | College/University | Graduate Degree | |
| University of California, Berkeley | College/University | Corporate Officer/Principal Doctorate Degree | |
| Wesleyan University | College/University | Undergraduate Degree | |
| University of Mumbai | College/University | Undergraduate Degree Doctorate Degree | |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Biotechnology | Corporate Officer/Principal | |
Ortho Biotech Products LP
 Ortho Biotech Products LP Pharmaceuticals: MajorHealth Technology Ortho Biotech Products LP provides innovative products and services which are designed to enhance the lives of individuals with serious chronic illnesses. The company's products include PROCRIT, DOXIL and LEUSTATIN. Ortho Biotech Products was founded in 1990 and is headquartered in Bridgewater, NJ | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer | |
Saama Technologies, Inc.
 Saama Technologies, Inc. Data Processing ServicesTechnology Services Saama Technologies, Inc. engages in the provision of consulting and systems integration services. It offers study conduct, study planning, and real world and commercial insight solutions The company was founded by Suresh Katta in 1997 and is headquartered in Campbell, CA. | Data Processing Services | Director/Board Member | |
Javelin Pharmaceuticals, Inc.
 Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| Kurukshetra University | College/University | Graduate Degree | |
Vlaams Instituut voor Biotechnologie - Flanders Institute
 Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | College/University | Chairman | |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Soudal NV
 Soudal NV Chemicals: SpecialtyProcess Industries Soudal NV engages in the manufacture and trade of sealants and adhesives. It offers polyurethane foams, hybrid polymers, technical aerosols, and chemical building products. The company was founded in 1966 and is headquartered in Turnhout, Belgium. | Chemicals: Specialty | Director/Board Member | |
| Trinity College, Cambridge | College/University | Doctorate Degree | |
Relmada Therapeutics, Inc. /Old/
 Relmada Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Relmada Therapeutics, Inc. is a holding company, which engages in the development of pharmaceutical drugs for the treatment of acute and chronic pains. It focuses in the developing of chronic pain due to cancer, musculoskeletal disorders, and peripheral neuropathy. The company was founded in 2000 and is headquartered in Blue Bell, PA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
Paras Group
 Paras Group Other Consumer ServicesConsumer Services Paras Group operates as a holding company with interest in personal care, healthcare, real estate and information technology businesses. The company was founded in 1960 and is headquartered in Ahmedabad, India | Other Consumer Services | General Counsel | |
Cilag GmbH International
 Cilag GmbH International Pharmaceuticals: MajorHealth Technology Cilag GmbH International conducts and coordinates international business in the pharmaceutical, chemical, consumer goods, medical products, and food products sectors. It also engages in the management of the corresponding research and development, particularly with reference to trading with products in these sectors. The company was founded in 1984 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Sagar Ratna Restaurants Pvt Ltd.
 Sagar Ratna Restaurants Pvt Ltd. RestaurantsConsumer Services Sagar Ratna Restaurants Pvt Ltd. operates chain of restaurants. It offers Indian food and also provides catering and delivery services. The company was founded in 1986 and is headquartered in New Delhi, India. | Restaurants | General Counsel | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| The Fuqua School of Business | College/University | Masters Business Admin | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree Undergraduate Degree | |
| RELMADA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
GS1 AISBL
 GS1 AISBL Miscellaneous Commercial ServicesCommercial Services GS1 AISBL is a Belgian company that provides supply chain standards to communicate with industry's customers, partners, and suppliers. The non-profit company is based in Brussels, BE, and has a global presence of subsidiaries in several regions. The company offers GS1 barcodes/GTINs that are necessary for most online and traditional retailers. The company optimizes the supply chain and life cycle management for Technical Industries. The company provides tools to calculate the check characters pair for the GMN and validate the structure and composition of the basic UDI-DI used for regulated healthcare medical devices. GS1 ID Keys give companies efficient ways to access information about items in their supply chains and share this information with trading partners. The company was founded in 1971, and the CEOs are Kathryn E. Wengel and Renaud de Barbuat. | Miscellaneous Commercial Services | Director/Board Member | |
Rejuvenate Biomed
 Rejuvenate Biomed Medical/Nursing ServicesHealth Services Rejuvenate Biomed is a clinical-stage platform and Belgian pipeline company founded in 2017 by Ann Belià « n. The company is committed to discovering and developing innovative combination drugs that can safely delay the onset of various age-related diseases. Rejuvenate Biomed has developed two proprietary drug discovery platforms, in silico combinagetm and in vivo celegagetm, to efficiently screen molecule libraries across a wide spectrum of age-related pathways. RJX-01, one of their drugs, is ready for a phase 2b clinical trial in sarcopenia, a musculoskeletal disease. The company is based on the Health Campus Limburg in Heusden-Zolder, BE. Ann Beliën has been the CEO since incorporation. | Medical/Nursing Services | Chairman | |
YishengBio Co., Ltd.
 YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Biotechnology | Director/Board Member | |
| LAKESHORE BIOPHARMA CO., LTD | Biotechnology | Chairman |
Statistiche
Distribuzione geografica
| Stati Uniti | 36 |
| India | 6 |
| Belgio | 6 |
| Cina | 3 |
| Svizzera | 2 |
Settori
| Health Technology | 22 |
| Consumer Services | 22 |
| Commercial Services | 4 |
| Finance | 2 |
| Technology Services | 2 |
Posizioni
| Corporate Officer/Principal | 120 |
| Director/Board Member | 112 |
| Chief Tech/Sci/R&D Officer | 44 |
| Undergraduate Degree | 40 |
| Independent Dir/Board Member | 34 |
Contatti più connessi
| Insiders | |
|---|---|
| Douglas G. Watson | 30 |
| Daniel Douglas von Hoff | 25 |
| C. Nicholson | 22 |
| Ajit Shetty | 19 |
| Martin Driscoll | 16 |
| Sergio Traversa | 15 |
| Bruce Williams | 14 |
| Ana I. Stancic | 14 |
| Marvin E. Jaffe | 13 |
| Loretta Itri | 12 |
| Anil Kapur | 12 |
| Richard Steinhart | 12 |
| Dragan Cicic | 11 |
| Matthew Beck | 10 |
| Mark Berger | 10 |
- Borsa valori
- Insiders
- Gary Siegel
- Connessioni Società
